Income Statement WELL Health Technologies Corp.
Equities
WELL
CA94947L1022
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.950 CAD | -3.19% |
|
-11.04% | -42.42% |
| Nov. 14 | Stifel Canada on WellStar Contract Win for OceanMD | MT |
| Nov. 13 | Well Health provides corporate update on Wellstar reflecting organic and inorganic growth wins | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 50.24M | 302M | 569M | 776M | 920M | |||||
Total Revenues | 50.24M | 302M | 569M | 776M | 920M | |||||
Cost of Goods Sold, Total | 29.02M | 149M | 266M | 404M | 557M | |||||
Gross Profit | 21.22M | 154M | 303M | 372M | 363M | |||||
Selling General & Admin Expenses, Total | 19.16M | 113M | 191M | 244M | 286M | |||||
Provision for Bad Debts | - | - | - | - | - | |||||
Stock-Based Compensation (IS) | 4.97M | 807K | 24.48M | 26.16M | 15.27M | |||||
Depreciation & Amortization - (IS) | 4.27M | 38.22M | 55.2M | 60.77M | 72.31M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | - | - | - | - | - | |||||
Other Operating Expenses, Total | 28.4M | 152M | 270M | 331M | 373M | |||||
Operating Income | -7.19M | 1.95M | 33.08M | 41.11M | -10.33M | |||||
Interest Expense, Total | -1.93M | -8.99M | -25.29M | -33.6M | -37.62M | |||||
Interest And Investment Income | 454K | 555K | 649K | 763K | 1.27M | |||||
Net Interest Expenses | -1.48M | -8.44M | -24.64M | -32.84M | -36.34M | |||||
Income (Loss) On Equity Invest. | -587K | -209K | -396K | -378K | -4.34M | |||||
Currency Exchange Gains (Loss) | -196K | -4.75M | -671K | 636K | 570K | |||||
Other Non Operating Income (Expenses) | 55.85K | 1.03M | -2M | -5.16M | -25.97M | |||||
EBT, Excl. Unusual Items | -9.4M | -10.42M | 5.37M | 3.37M | -76.42M | |||||
Merger & Related Restructuring Charges | -3.22M | -9.99M | -2.49M | -6.59M | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 6.9M | - | 282K | 42.56M | 101M | |||||
Gain (Loss) On Sale Of Assets | - | - | 5.21M | 1.57M | 11.82M | |||||
Legal Settlements | - | - | - | - | -20.44M | |||||
Other Unusual Items | -1.86M | -4.57M | 9.16M | -21.41M | -7.46M | |||||
EBT, Incl. Unusual Items | -7.57M | -24.97M | 17.52M | 19.5M | 8.99M | |||||
Income Tax Expense | -4.36M | 5.92M | -1.15M | 2.86M | -20.1M | |||||
Earnings From Continuing Operations | -3.21M | -30.9M | 18.68M | 16.64M | 29.1M | |||||
Earnings Of Discontinued Operations | - | - | - | - | - | |||||
Net Income to Company | -3.21M | -30.9M | 18.68M | 16.64M | 29.1M | |||||
Minority Interest | -476K | -12.89M | -17.31M | -16.56M | 3.51M | |||||
Net Income - (IS) | -3.69M | -43.79M | 1.37M | 82K | 32.61M | |||||
Net Income to Common Incl Extra Items | -3.69M | -43.79M | 1.37M | 82K | 32.61M | |||||
Net Income to Common Excl. Extra Items | -3.69M | -43.79M | 1.37M | 82K | 32.61M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.03 | -0.23 | 0.01 | 0 | 0.13 | |||||
Basic EPS - Continuing Operations | -0.03 | -0.23 | 0.01 | 0 | 0.13 | |||||
Basic Weighted Average Shares Outstanding | 134M | 191M | 221M | 237M | 247M | |||||
Net EPS - Diluted | -0.03 | -0.23 | 0.01 | 0 | 0.13 | |||||
Diluted EPS - Continuing Operations | -0.03 | -0.23 | 0.01 | 0 | 0.13 | |||||
Diluted Weighted Average Shares Outstanding | 134M | 191M | 221M | 237M | 255M | |||||
Normalized Basic EPS | -0.05 | -0.1 | -0.06 | -0.06 | -0.18 | |||||
Normalized Diluted EPS | -0.05 | -0.1 | -0.06 | -0.06 | -0.17 | |||||
Supplemental Items | ||||||||||
EBITDA | -4.76M | 35.27M | 80.22M | 91.33M | 45.65M | |||||
EBITA | -5.06M | 32.55M | 75.9M | 86.81M | 39.86M | |||||
EBIT | -7.19M | 1.95M | 33.08M | 41.11M | -10.33M | |||||
EBITDAR | -4.82M | 35.21M | 80.18M | - | - | |||||
Total Revenues (As Reported) | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 57.6 | -23.71 | -6.56 | 14.67 | -223.58 | |||||
Total Current Taxes | 506K | - | 2.88M | 12.68M | 9.23M | |||||
Total Deferred Taxes | -4.87M | - | -4.03M | -9.82M | -29.33M | |||||
Normalized Net Income | -6.35M | -19.4M | -13.95M | -14.45M | -44.25M | |||||
Interest on Long-Term Debt | 1.11M | 2.54M | 10.32M | 12.37M | 14.57M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | - | - | - | - | |||||
Marketing Expenses | 1.59M | 15.78M | 47.7M | 64.29M | 84.6M | |||||
Selling and Marketing Expenses | 1.59M | 15.78M | 47.7M | 64.29M | 84.6M | |||||
General and Administrative Expenses | 17.57M | 96.95M | 143M | 180M | 201M | |||||
Research And Development Expense From Footnotes | - | - | - | 3.46M | 3.18M | |||||
Net Rental Expense, Total | -55.85K | -64K | -32K | - | - | |||||
Imputed Operating Lease Interest Expense | -40.44K | -21.64K | -17.03K | - | - | |||||
Imputed Operating Lease Depreciation | -15.41K | -42.36K | -14.97K | - | - | |||||
Maintenance & Repair Expenses, Total | - | - | - | - | - | |||||
Stock-Based Comp., G&A Exp. (Total) | - | 20.2M | - | - | - | |||||
Stock-Based Comp., Other (Total) | 4.97M | 807K | 24.48M | 26.16M | 15.27M | |||||
Total Stock-Based Compensation | 4.97M | 21.01M | 24.48M | 26.16M | 15.27M |
- Stock Market
- Equities
- WELL Stock
- Financials WELL Health Technologies Corp.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















